Microsoft warns tax-season phishing hit 29,000 users via IRS lures, enabling credential theft and RMM-based access.
Get the latest international news and world events from around the world.
Microsoft Azure Monitor alerts abused for callback phishing attacks
Microsoft Azure Monitor alerts are being abused to send callback phishing emails that impersonate warnings from the Microsoft Security Team about unauthorized charges on your account.
Azure Monitor is Microsoft’s cloud-based monitoring service that collects and analyzes data from Azure resources, applications, and infrastructure. It enables users to track performance, notify about billing changes, detect issues, and trigger alerts based on various conditions.
Over the past month, numerous people have reported receiving Azure Monitor alerts warning of suspicious charges or invoice activity on their accounts, urging them to call an enclosed phone number.
Tycoon2FA phishing platform returns after recent police disruption
The Tycoon2FA phishing-as-a-service (PhaaS) platform that Europol and partners disrupted on March 4 has already returned to previously observed activity levels.
Microsoft led the technical disruption, which involved seizing 330 domains part of Tycoon2FA’s backbone infrastructure that included control panels and phishing pages used in attacks.
However, the disruption caused by the law enforcement was short-lived, as CrowdStrike noticed the cybercrime service return to normal operational volumes within days.
Micro Planets: Building Artificial Worlds with Black Hole Cores
What if we built entire planets around tiny black holes? Explore engineered micro worlds, artificial gravity, and the future of compact megastructures.
Get Nebula using my link for 50% off an annual subscription: https://go.nebula.tv/isaacarthur.
Watch my exclusive video Lazarus Protocols: https://nebula.tv/videos/isaacarthur–… out Practical Engineering: https://nebula.tv/practical-engineeri… 🛒 SFIA Merchandise: https://isaac-arthur-shop.fourthwall… 🌐 Visit our Website: http://www.isaacarthur.net ❤️ Support us on Patreon: / isaacarthur ⭐ Support us on Subscribestar: https://www.subscribestar.com/isaac-a… 👥 Facebook Group:
/ 1,583,992,725,237,264 📣 Reddit Community:
/ isaacarthur 🐦 Follow on Twitter / X:
/ isaac_a_arthur 💬 SFIA Discord Server:
/ discord Credits: Micro Planets — Building Artificial Worlds with Black Hole Cores Written, Produced & Narrated by: Isaac Arthur Graphics from Jeremy Jozwik & Ken York Music Courtesy of Chris Zabriskie & Stellardrone Select imagery/video supplied by Getty Images Chapters 0:00 Intro 1:14 Small Worlds, Big Numbers 7:54 What to make it from? 11:53 What is a Micro Planet, and what is it like? 17:50 So could you go even smaller? 21:20 Nebula.
Check out Practical Engineering: https://nebula.tv/practical-engineeri…
🛒 SFIA Merchandise: https://isaac-arthur-shop.fourthwall…
🌐 Visit our Website: http://www.isaacarthur.net.
❤️ Support us on Patreon: / isaacarthur.
⭐ Support us on Subscribestar: https://www.subscribestar.com/isaac-a…
👥 Facebook Group: / 1583992725237264
📣 Reddit Community: / isaacarthur.
🐦 Follow on Twitter / X: / isaac_a_arthur.
💬 SFIA Discord Server: / discord.
Credits:
Micro Planets — Building Artificial Worlds with Black Hole Cores.
Written, Produced & Narrated by: Isaac Arthur.
Graphics from Jeremy Jozwik & Ken York.
Music Courtesy of Chris Zabriskie & Stellardrone.
Select imagery/video supplied by Getty Images.
Chapters.
0:00 Intro.
1:14 Small Worlds, Big Numbers.
7:54 What to make it from?
11:53 What is a Micro Planet, and what is it like?
17:50 So could you go even smaller?
21:20 Nebula
New Experimental Drug Shrinks Tumors in Prostate Cancer Clinical Trial
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a “masked T-cell engager”. This type of immunotherapy ignites our own immune arsenal to fight cancer.
In the trial, which is still in progress and has not yet undergone peer review, patients with advanced prostate cancer who had failed to respond to other treatments were given VIR-5500.
Remarkably, initial findings showed that in the patients who received the highest doses, 82% saw reductions in their PSA (prostate-specific antigen) levels – a commonly used measure of prostate cancer.
